Business Update3 May 2024, 01:39 am
Procter & Gamble Health Ltd Announces Q3 Sales of 248 Crores, PAT at 46 Crores
AI Summary
Procter & Gamble Health Ltd recently announced their unaudited financial results for the quarter ended March 31, 2024. The company reported sales of 248 crores and a Profit After Tax (PAT) of 46 crores for the quarter, showing a decline from the corresponding period last year. Despite the decrease, the company's Managing Director, Milind Thatte, expressed confidence in the company's growth strategy and ongoing efforts to enhance operational efficiency and explore innovative solutions.
Key Highlights
- Company reported sales of 248 crores for Q3 2023-24
- Profit After Tax stood at 46 crores
- Sales for the nine-month period was 852 crores
- PAT for nine-month period was 184 crores
- Continued efforts to strengthen reach and distribution
- Saw sales recover in March and April